← Open Payments lookup

CHELSEA CRILLY: Open Payments

NPI 1851865042 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$7,048 in 76 payments from 25 companies in 2025. Trend: 2023 $8,174 · 2024 $19,970 · 2025 $7,048

Speaker / faculty: $4,144Food & beverage: $1,700Travel & lodging: $1,205
CompanyPaymentsAmount
Apellis Pharmaceuticals, Inc.14$5,702
AstraZeneca Pharmaceuticals LP8$206
Janssen Biotech, Inc.12$193
Merck Sharp & Dohme LLC5$123
Novartis Pharmaceuticals Corporation4$109
Daiichi Sankyo Inc.4$80
ABBVIE INC.3$72
Regeneron Healthcare Solutions, Inc.3$57
Genmab U.S., Inc.2$56
Takeda Pharmaceuticals U.S.A., Inc.2$55

Products named: Empaveli, TECVAYLI, ENHERTU, IMFINZI, KEYTRUDA, Epkinly, RYBREVANT, SCEMBLIX.

Industry payments across TX — which companies pay providers there.